Oboi Laboratories

Oboi Laboratories is a biotechnology company focused on developing therapies to reverse biological aging and treat age-related diseases. The company utilizes epigenetic reprogramming and cellular rejuvenation technologies to restore youthful gene expression patterns to cells and tissues. Their research aims to extend healthy human lifespan by targeting the fundamental drivers of biological aging, specifically focusing on conditions like sarcopenia and skin degradation. Oboi's platform leverages the controlled application of Yamanaka factors to safely rejuvenate tissues without inducing pluripotency. The company is currently in the pre-clinical stage, advancing its pipeline of regenerative therapies.